Home  Top Stories  Sports  Entertainment  Health News  Business  Personal Finance 
Real Estate  Business Finance  Insurance  Consulting 
Tax News  Forum




Featured Articles







Avastin in Combination With Chemotherapy Stabilizes Breast Cancer Twice as Long as Chemo Alone - Advanced Stages Tested - Early Stages Next

March 23rd 2006

Avastin in Combination With Chemotherapy Stabilizes Breast Cancer Twice as Long as Chemo Alone - Advanced Stages Tested - Early Stages Next


Researchers say that combining the drug Avastin with standard chemotherapy can keep breast cancer under control for a longer period of time in patients with the advanced disease.  Now the researchers want to find out if the combination therapy will help patients when the disease has not metastasized. 

Doctors combined the drug with the chemotherapy treatment Taxol in 722 patients.  They found that the cancer was stable for 11.4 months in women who received the drug combo compared to 6.11 months in patients that were only given Taxol.  This combined therapy kept the cancer under control for almost twice as long as relying on the chemotherapy alone. 

It is common for doctors to prescribe multiple drugs to treat an illness.  In the case of Avastin and Taxol, the chemotherapy drug attacks the tumors directly and Avastin interferes with the formation of blood vessels, effectively starving the tumors for nutrients.


Herceptin has showed promise fighting breast caner in earlier studies.  The problem is, Herceptin can only help women with Her2 positive tumors.  These tumors accounts for only one fifth of the breast cancer cases.  The vast majority of cancer patients can not benefit from Herceptin.   

Avastin appears to have no side affects according to Dr. Robin Zon, who presented the findings to the European Breast Cancer Conference in Nice, France.  The next step is determined if Avastin can be used as an effective treatment in early stages of breast cancer. 

Avastin (bevacizumab) has helped patients with colorectal and lung cancer as well.  The drug is made by Roche Holding AG and its majority-owned U.S. biotech arm Genentech Inc. 

Comment on this Article at our Forum

Submit your own Article

Cancer Prevention and Treatments

  RSS Feeds to Cancer News

  RSS Feed to our health News

  RSS Feed to all of our News

Add to Google Add to My AOL
Add to My Yahoo! Subscribe with Pluck RSS reader
Subscribe in NewsGator Online
Add this feed to Your C-Net
Subscribe in Bloglines Subscribe in Rojo

By Dan Wilson
Best Syndication

Books on Cancer

Keywords and misspellings: prostrate hormane treetments brane braine canser cancar  abc world news tonigh prosetate ransel

Web BestSyndication.com

About   Contact   site map

Copyright 2005 Best Syndication                                            Last Updated Saturday, July 10, 2010 09:50 PM